Tried Semaglutide and Tirzepatide and Still Not Losing Weight? Why the Answer Isn’t Always a Different Medication — and What a Physician Should Actually Investigate Next

If you’ve been on a GLP-1 medication, done everything right, and the scale still isn’t moving — you’re not imagining it. GLP-1 not working for weight loss is one of the most common and frustrating patterns physicians see in medical weight loss practices. The instinct is to switch medications, increase the dose, or assume the patient isn’t following the plan. But experienced physicians know that when semaglutide or tirzepatide stops working — or never really worked to begin with — the answer is almost always hiding in the body’s underlying biology. And that biology shows up in your blood work.

At Made Ya Skinny in Magnolia, TX, our physician-supervised approach goes beyond writing a prescription. We treat the whole metabolic picture — because for many patients, especially women between 35 and 55, there are physiological reasons a medication works for someone else but not for them. This post walks through what those reasons are, what a physician should be investigating, and what your next steps can look like.

Why GLP-1 Medications Sometimes Don’t Work — or Stop Working

GLP-1 receptor agonists like semaglutide and tirzepatide are genuinely powerful tools. They reduce appetite, slow gastric emptying, improve insulin sensitivity, and help regulate blood sugar in ways that support meaningful weight loss for many patients. But they are not magic bullets. They work with your metabolism — and if your metabolism is fighting back due to an underlying imbalance, the medication can only do so much.

Here are the most common reasons physicians investigate when a patient reports a tirzepatide plateau or no weight loss on semaglutide:

1. Thyroid Dysfunction — Especially Subclinical Hypothyroidism

The thyroid controls your metabolic rate. When it’s underperforming — even slightly — your body burns calories more slowly, holds onto weight more stubbornly, and resists almost every weight loss intervention. Standard TSH panels often miss this. A thorough physician will look at Free T3, Free T4, and Reverse T3, which can reveal a conversion problem even when TSH looks normal. Subclinical hypothyroidism is especially common in women over 40 and is frequently overlooked in standard screenings.

2. Cortisol Dysregulation

Chronic stress drives chronically elevated cortisol. Elevated cortisol tells your body to store fat — particularly around the midsection — and actively works against the appetite-regulating signals that GLP-1 medications are trying to send. If your cortisol pattern is dysregulated, a medication that suppresses appetite cannot easily override the hormonal instruction to store energy. This is not a willpower problem. It is a biochemistry problem.

3. Sex Hormone Imbalances — Estrogen, Progesterone, and Testosterone

Hormonal shifts are one of the most underdiagnosed drivers of weight loss resistance in women. Declining estrogen changes how and where your body stores fat. Low progesterone disrupts sleep, which then elevates cortisol and increases appetite-driving hormones like ghrelin. Low testosterone — yes, women need it too — reduces lean muscle mass, and lean muscle is what burns calories at rest.

Many women on GLP-1 medications who aren’t seeing results have an underlying hormonal picture that is actively working against the medication. This is why our physician-supervised GLP-1 weight loss program incorporates hormone evaluation alongside GLP-1 management — because treating one without the other often means incomplete results.

4. Nutrient Deficiencies That Stall Metabolism

GLP-1 medications reduce appetite significantly. That’s the point. But reduced food intake means reduced intake of critical micronutrients. Deficiencies in magnesium, vitamin D, B12, zinc, and iron are extremely common in patients on these medications — and each of these plays a direct role in metabolic function, energy production, and the body’s ability to burn fat efficiently. A patient who is low in vitamin D and magnesium is a patient whose metabolism has been quietly slowed. No amount of dose adjustment will fix a nutrient deficiency.

5. Insulin Resistance That Hasn’t Fully Responded

Tirzepatide acts on both GLP-1 and GIP receptors, making it particularly effective for patients with significant insulin resistance. But insulin resistance exists on a spectrum, and some patients have accompanying conditions — elevated fasting insulin, early fatty liver, or PCOS — that require more targeted intervention than the medication alone can provide. Understanding where a patient actually sits on that spectrum requires the right labs, not guesswork.

6. Digestive Enzyme Deficiency and Gut Function

A less commonly discussed factor: GLP-1 plateau digestive enzymes. GLP-1 medications slow gastric emptying, and in some patients this interacts with already-compromised digestive enzyme production. When digestion is impaired, nutrient absorption suffers — worsening the deficiency cycle described above. Physicians investigating a persistent plateau will sometimes look at inflammatory markers and gut-related labs to assess whether this is a contributing factor.

What “Trying a Different Medication” Actually Means

There’s a meaningful clinical difference between switching medications because the mechanism doesn’t fit the patient’s biology — and switching because the prescriber hasn’t investigated why the current medication isn’t working.

Some patients genuinely do better on tirzepatide than semaglutide, or vice versa. Tirzepatide’s dual-agonist action makes it more effective for patients whose primary driver is insulin resistance, while semaglutide’s single-agonist profile may be better suited for other presentations. A physician who understands this distinction can make a considered recommendation. A physician who simply escalates to the next drug without investigating is missing the clinical picture.

If you’ve been told to just try a higher dose or a different drug without anyone running a comprehensive panel, that’s a gap in your care — and it’s worth addressing.

What a Functional Medicine Approach to GLP-1 Resistance Looks Like

When GLP-1 stops working or weight comes back, the answer is often in the blood work. Made Ya Skinny takes a functional medicine approach — running the right labs, reading them correctly, and building a plan around what your body actually needs rather than just increasing the dose.

That means looking beyond the standard metabolic panel. It means evaluating thyroid function comprehensively, assessing sex hormones at the right time in a patient’s cycle, checking fasting insulin — not just fasting glucose — and identifying the nutrient deficiencies that are quietly slowing the system down.

When those findings come back, the treatment plan reflects them. That might mean adding BHRT (bioidentical hormone replacement therapy) to address the hormonal factors that are working against the medication. It might mean targeted supplementation to correct the deficiencies that are capping metabolic function. It might mean a dose adjustment informed by clinical data rather than by the fact that the previous dose didn’t seem to work.

This is what medical weight loss in Magnolia, TX — and through telehealth across Texas and other states — looks like when it’s done with a full clinical picture rather than a template.

Who This Applies To

This pattern is especially common in:

• Women between 35 and 55 who are in perimenopause or post-menopause
• Patients who lost weight initially on a GLP-1 medication and then plateaued
• Patients who never responded well to the medication despite dose increases
• Anyone who has regained weight after stopping or reducing the medication
• Patients with a history of thyroid issues, PCOS, or adrenal dysfunction

If any of these descriptions fit you, the answer likely isn’t that GLP-1 medications don’t work for your body. The answer is that your body needs more investigation before the medication can do its job effectively. Individual results vary, and a physician evaluation is the only way to identify what’s actually going on.

What to Do Next

If you’ve been frustrated by a semaglutide plateau or no weight loss on tirzepatide, the single most productive step you can take is a comprehensive physician consultation — one where someone actually looks at your labs, your hormones, your history, and your current plan together. Not a five-minute follow-up. A real evaluation.

Made Ya Skinny serves patients in Magnolia, Cypress, The Woodlands, Conroe, Willis, Montgomery, Tomball, and North Houston — and telehealth patients across multiple states. Our physician-led approach is designed specifically for patients who haven’t gotten the results they expected and want to understand why.

Take the next step and book your $17 visit — a physician consultation where we actually look at your full picture and build a plan around what your body needs. Because the right answer isn’t always a different medication. Sometimes it’s a better investigation.